NICE U-turn on Boehringer’s Pradaxa
November 1, 2011Sales and Marketing NICE, Pradaxa
NICE is now recommending Boehringer Ingelheim’s Pradaxa for stroke prevention after initially rejecting the drug on cost-effectiveness issues. NICE has …
Shadow Commissioning Board goes live
October 31, 2011Medical Communications Commissioning Board, DH, NHS
The NHS Commissioning Board, the new central and powerful committee that will co-ordinate the health service in England, has been …
UK researchers claim advance in chiral manufacturing
October 31, 2011Manufacturing and Production Cambridge University, chiral manufacturig, chiral manufacturing
Researchers from the UK says a new technique which uses metal surfaces as templates to make drug compounds with specific …
Working Life: Adaptimmune’s Helen Tayton-Martin
October 31, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Working Life
Helen Tayton-Martin who is an executive director at Adaptimmune, talks to Pharmafocus about her role and working in cell therapy. …
Contract research news in brief
October 31, 2011Manufacturing and Production, Research and Development CRO, manufacturing and production
PPD looks set to go private, WuXi and Quintiles stride down the acquisition trail plus updates from TrialReach and Aragen …
FDA’s rejection of Avastin creates conflict
October 31, 2011Research and Development, Sales and Marketing FDA, avastin, breast cancer
Oncology experts have expressed concern at the FDA’s rejection of Roche’s Avastin for the treatment of advanced breast cancer. A …
Carsten Schroeder appointed interim president of Novartis Diagnostics
October 31, 2011Sales and Marketing Novartis
Schroeder was previously vice president of Novartis Diagnostics for commercial operations in Europe, the Middle East and Africa. He will …
Novartis job cuts protest
October 31, 2011Manufacturing and Production, Sales and Marketing Novartis, job cuts, manufacturing and production
Protesters have been demonstrating outside the home of Novartis chairman Daniel Vasella and in the streets of Basel, Switzerland, in …
Core products boost Merck’s results
October 31, 2011Medical Communications, Sales and Marketing Gardasil, Merck, Victrelis
Sales of core products and favourable exchange rates have helped Merck grow its revenue in a tough environment. Worldwide sales …
Brilique gains NICE approval
October 31, 2011Sales and Marketing ACS, Brilique, NICE, Plavix, clopidogrel
AstraZeneca’s Brilique has been approved by NICE for use in combination with aspirin as an option to treat patients with …
Boehringer agrees Pradaxa kidney function warning
October 30, 2011Sales and Marketing AF, EMA, Pradaxa, renal function
Boehringer Ingelheim is to alert doctors in Europe of the need to check patients’ kidney function before prescribing anticoagulant Pradaxa. …
Dr Reddy’s says two plants clear FDA inspections
October 28, 2011Manufacturing and Production Dr Reddy's, FDA 483s, India, generics
Two manufacturing facilities operated by Indian drugmaker Dr Reddy’s Laboratories successfully passed inspections by the FDA, although a plant in …
Emerging markets help Bayer through tough quarter
October 28, 2011Sales and Marketing Bayer, Xarelto, emerging markets
Bayer has posted modest results for the third quarter, with growth in emerging markets compensating for austerity measures in Europe …
PM Society appoints new general manager
October 28, 2011Medical Communications pm society
The Pharmaceutical Marketing Society has appointed Anneliese Cameron as its new general manager. Anneliese will be joining the Society on …
Publicis merges digital agencies into larger group
October 28, 2011Medical Communications Digitas Health, Razorfish, digital, publicis
Digital agencies Digitas Health and Razorfish Health are to be merged into the larger Publicis Healthcare Communications Group (PHCG).PHCG is …
AstraZeneca weathers patent expiry storm
October 27, 2011Sales and Marketing AstraZeneca, AstraZenecca, q3 2011
AstraZeneca saw its revenue decline in the third quarter due to an onslaught of patent expiries, but still saw its …
Lessons from the world of iPad detailing
October 27, 2011Medical Communications
This is an article for those who have chosen the iPad as an e-detailing tool. It’s not an argument on …
Alex Butler leaves Janssen to set up Social Moon pharma network
October 27, 2011Medical Communications Alex Bytler, Jansse, Janssen, comms
Social media guru Alex Butler has left Janssen to establish Social Moon, a digital-only marketing and comms agency for the …
Lansley talks tough on failing hospitals
October 27, 2011Medical Communications Andrew Lansley, NHS reforms
The health secretary Andrew Lansley says he will intervene to remove management boards of hospitals which can’t clear debts or …
Biogen’s MS drug hits phase III targets
October 27, 2011Sales and Marketing BG-12, Biogen, MS
Biogen’s potential blockbuster MS drug BG-12 has met its primary endpoint in a late-stage trial. BG-12 (dimethyl fumarate) tablets …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
